Disruption of PH-kinase domain interactions leads to oncogenic activation of AKT in human cancers
出版年份 2012 全文链接
标题
Disruption of PH-kinase domain interactions leads to oncogenic activation of AKT in human cancers
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 109, Issue 47, Pages 19368-19373
出版商
Proceedings of the National Academy of Sciences
发表日期
2012-11-08
DOI
10.1073/pnas.1204384109
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly
- (2012) Jeong Ho Lee et al. NATURE GENETICS
- Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape
- (2011) Margrith E Mattmann et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Disruption of the Interface between the Pleckstrin Homology (PH) and Kinase Domains of Akt Protein Is Sufficient for Hydrophobic Motif Site Phosphorylation in the Absence of mTORC2
- (2011) Noel A. Warfel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Mosaic Activating Mutation inAKT1Associated with the Proteus Syndrome
- (2011) Marjorie J. Lindhurst et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Activating Mutation of AKT2 and Human Hypoglycemia
- (2011) K. Hussain et al. SCIENCE
- Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors
- (2010) Josef R. Bencsik et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Akt inhibitors in clinical development for the treatment of cancer
- (2010) Sumanta Kumar Pal et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Diverse somatic mutation patterns and pathway alterations in human cancers
- (2010) Zhengyan Kan et al. NATURE
- Activated MEK cooperates with Ink4a/Arf loss or Akt activation to induce gliomas in vivo
- (2010) J P Robinson et al. ONCOGENE
- Physical Association of PDK1 with AKT1 Is Sufficient for Pathway Activation Independent of Membrane Localization and Phosphatidylinositol 3 Kinase
- (2010) Zhiyong Ding et al. PLoS One
- Crystal Structure of Human AKT1 with an Allosteric Inhibitor Reveals a New Mode of Kinase Inhibition
- (2010) Wen-I Wu et al. PLoS One
- Somatic Mutations in p85α Promote Tumorigenesis through Class IA PI3K Activation
- (2009) Bijay S. Jaiswal et al. CANCER CELL
- Role of a Novel PH-Kinase Domain Interface in PKB/Akt Regulation: Structural Mechanism for Allosteric Inhibition
- (2009) Véronique Calleja et al. PLOS BIOLOGY
- PTEN and the PI3-Kinase Pathway in Cancer
- (2008) Nader Chalhoub et al. Annual Review of Pathology-Mechanisms of Disease
- Molecular Mechanism of an Oncogenic Mutation That Alters Membrane Targeting: Glu17Lys Modifies the PIP Lipid Specificity of the AKT1 PH Domain†
- (2008) Kyle E. Landgraf et al. BIOCHEMISTRY
- A novel AKT3 mutation in melanoma tumours and cell lines
- (2008) M A Davies et al. BRITISH JOURNAL OF CANCER
- Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity
- (2008) N. Rhodes et al. CANCER RESEARCH
- The PI3K/Akt Pathway: Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors
- (2008) Craig Lindsley et al. CURRENT CANCER DRUG TARGETS
- Somatic mutations affect key pathways in lung adenocarcinoma
- (2008) Li Ding et al. NATURE
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells
- (2008) S Horn et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started